Yesterday, Nov. 3, 2015, 89 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $9.84 to $10,914,626.52.

Highlighted Stocks Traded by Insiders:

Pacific Mercantile Bancorp (PMBC) - FREE Research Report

Romir Bosu, who is Director at Pacific Mercantile Bancorp, bought 14,620 shares at $6.81 on Nov. 3, 2015. Following this transaction, the Director owned 14,620 shares meaning that the stake was boosted by 100% with the 14,620-share transaction.

The shares most recently traded at $6.76, down $0.05, or 0.74% since the insider transaction. Historical insider transactions for Pacific Mercantile Bancorp go as follows:

  • 4-Week # shares bought: 16,600
  • 4-Week # shares sold: 26,307
  • 12-Week # shares bought: 16,600
  • 12-Week # shares sold: 26,307
  • 24-Week # shares bought: 33,900
  • 24-Week # shares sold: 26,307

The average volume for Pacific Mercantile Bancorp has been 49,800 shares per day over the past 30 days. Pacific Mercantile Bancorp has a market cap of $130.9 million and is part of the financial sector and banking industry. Shares are down 2.98% year-to-date as of the close of trading on Tuesday.

Pacific Mercantile Bancorp operates as the bank holding company for the Pacific Mercantile Bank that provides commercial banking products and services to small and medium-size businesses, professionals, and general public in Southern California. Currently, there are no analysts who rate Pacific Mercantile Bancorp a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on PMBC - FREE

TheStreet Quant Ratings

rates Pacific Mercantile Bancorp as a

hold

. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, expanding profit margins and increase in stock price during the past year. However, as a counter to these strengths, we find that the company's revenue growth has not been good. Get the full

Pacific Mercantile Bancorp Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Avery Dennison (AVY) - FREE Research Report

Alford Bradley A, who is Director at Avery Dennison, bought 126 shares at $64.84 on Nov. 3, 2015. Following this transaction, the Director owned 7,064 shares meaning that the stake was boosted by 1.82% with the 126-share transaction.

The shares most recently traded at $64.90, up $0.06, or 0.08% since the insider transaction. Historical insider transactions for Avery Dennison go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 5,000
  • 24-Week # shares sold: 5,000

The average volume for Avery Dennison has been 734,000 shares per day over the past 30 days. Avery Dennison has a market cap of $6.0 billion and is part of the consumer goods sector and consumer durables industry. Shares are up 25.5% year-to-date as of the close of trading on Tuesday.

Avery Dennison Corporation produces and sells pressure-sensitive materials worldwide. It operates through Pressure-Sensitive Materials, Retail Branding and Information Solutions, and Vancive Medical Technologies segments. The stock currently has a dividend yield of 2.25%. The company has a P/E ratio of 21.5. Currently, there are 5 analysts who rate Avery Dennison a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AVY - FREE

TheStreet Quant Ratings

rates Avery Dennison as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Avery Dennison Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Walgreens Boots Alliance (WBA) - FREE Research Report

Lederer John Anthony, who is Director at Walgreens Boots Alliance, bought 10,000 shares at $84.88 on Nov. 3, 2015. Following this transaction, the Director owned 20,000 shares meaning that the stake was boosted by 100% with the 10,000-share transaction.

The shares most recently traded at $86.70, up $1.82, or 2.1% since the insider transaction. Historical insider transactions for Walgreens Boots Alliance go as follows:

  • 4-Week # shares sold: 3,500
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 3,500
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 3,500

The average volume for Walgreens Boots Alliance has been 5.0 million shares per day over the past 30 days. Walgreens Boots Alliance has a market cap of $94.2 billion and is part of the services sector and retail industry. Shares are up 15.79% year-to-date as of the close of trading on Tuesday.

Walgreens Boots Alliance, Inc., together with its subsidiaries, operates a network of drugstores in the United States. It provides consumer goods and services, pharmacy, and health and wellness services through drugstores, as well as through mail, and by telephone and online. The stock currently has a dividend yield of 1.66%. The company has a P/E ratio of 21.6. Currently, there are 10 analysts who rate Walgreens Boots Alliance a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WBA - FREE

TheStreet Quant Ratings

rates Walgreens Boots Alliance as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

Walgreens Boots Alliance Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.